Wilmington, Delaware, United States, Transparency Market Research Inc. – According to Transparency Market Research’s latest report on the global transcatheter embolization and occlusion devices market for the historical period 2017–2018 and forecast period 2019–2027.
Wilmington, Delaware, United States, Transparency Market Research Inc. – According to Transparency Market Research’s latest report on the global transcatheter embolization and occlusion devices market for the historical period 2017–2018 and forecast period 2019–2027. Rise in prevalence of chronic diseases, technological advancements, increase in patient awareness and health care expenditure, and surge in need of treatment of complex diseases drive the global market during the forecast period.
According to the report, the global transcatheter embolization and occlusion devices market was valued at US$ 2,957.4 Mn in 2018 and is anticipated to expand at a CAGR of 7.8 % from 2019 to 2027. In terms of volume, the global transcatheter embolization devices were accounted at 73,92,954 units in 2018.
Request Sample of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2242
Increase in Spectrum of Transcatheter Embolization in Gynecologic and Obstetric Indications: Key Drivers
Transcatheter embolization is a useful therapeutic option for a wide range of gynecologic and obstetric abnormalities. Transcatheter embolization procedures performed with the use of radiologic imaging for guidance are minimally invasive and could prevent surgery, thereby decreasing morbidity and mortality and conserving a patient’s future fertility potential.
Under experienced interventional radiologists and essential technical support, transcatheter embolization can be performed for the treatment of numerous lesions in the female pelvis, including obstetric-gynecologic hemorrhage, advanced-stage malignancy, ectopic pregnancy, and arteriovenous malformation. It can also be used to treat pelvic congestion syndrome and symptomatic uterine fibroids in women who have undergone appropriate screening. Global success rate of 85% and higher have been reported in women treated with embolization for uterine fibroids.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=2242
Development of New Materials for Catheterization and Embolization Boost Market Growth
As new materials for catheterization and embolization are developed, to provide greater vascular occlusion with regard to clinical performance and lower the complication rates. Many new agents have appeared on the market in the past several years.
Liquid embolic agents under investigation are primarily targeted toward the treatment of aneurysms, AVMs, and HCC. The administration of currently available liquid embolic polymers, NBCA, Onyx, and PHIL are associated with the introduction of toxic compounds. Hence, several groups are investigating new in situ gelling polymer systems that avoid the use of toxic byproducts or solvents.
The number of flow-directed embolic materials is expanding. The microspheres are prepared using a suspension polymerization process of poly(lactide-co-glycolide)-block-poly(ethylene glycol) crosslinker and PEGMA monomer. Co-monomers methacrylic acid (MA) and 2-methylene-1,3-dioxepane (MDO) were integrated to refine its properties.
Ask for References - https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=2242
Post Embolization Syndrome to Hamper Market
Embolization is a useful technique in the therapeutic management of patients with vascular injuries caused by trauma, liver surgery, or percutaneous procedures. Such injuries are unusual; however, the presence of hemobilia or hemoperitoneum resulting from pseudoaneurysm or laceration of a blood vessel could put a patient critically at risk. Selective embolization of the injury provides excellent results as far as hemostasis is concerned (86%), although an associated morbidity of 58% has been described, which is basically connected with bile leakage, liver abscesses, and/or necrosis. Such lesions should, therefore, be treated on an individual basis, with full awareness of the possible consequences of a technique that is not risk-free.
The most common complication after embolization, the cause of which is still not properly understood, is the occurrence of fever, pain in the right hypochondrium, and a rise in transaminases. High temperature (< 38.5°C) may occur between 41% and 74% of cases and seems to be related to the presence of necrosis of the tumor and healthy tissue. Cytolysis (increase in transaminases), which has been observed in up to 93% of cases, is related to damage to healthy (noncancerous) hepatocytes.
Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=2242
Global Transcatheter Embolization and Occlusion Devices Market: Competitive Landscape
This report profiles major players in the global transcatheter embolization and occlusion devices market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
The global transcatheter embolization and occlusion devices market is highly fragmented, with the presence of a number of international as well as regional players
Leading players operating in the global transcatheter embolization and occlusion devices market are
- BTG plc
- Boston Scientific Corporation
- Medtronic plc
- Penumbra, Inc.
- Cook Medical
- Edwards Lifesciences Corporation
- Merit Medical Systems
- Johnson & Johnson Services, Inc.
- Pfizer, Inc.
- Stryker Corporation
- Terumo Corporation
- Sirtex Medical Limited
- Abbott Laboratories.
More Trending Reports by Transparency Market Research –
Wound Irrigation Systems Market: Rising demand for wound care products in elderly population propelling revenue streams; opportunities in Asia Pacific market to expand at remarkable growth rate during forecast period.
Trauma Implants Market: The global trauma implants market is expected to cross the value of US$ 16.7 Bn by the end of 2031.
Medical Sensors Market: The global medical sensors market is expected to reach the value of US$ 32.15 Bn by the end of 2028.
Skin Care Devices Market: The global skincare devices market is expected to reach the value of US$ 23.9 Bn by the end of 2028.
Medical Equipment Rental Market: The global medical equipment rental market is expected to reach the value of US$ 70.95 Bn by the end of 2028.
Southern Europe & Middle East Medical Robotics Market: The Southern Europe & Middle East medical robotics market is expected to reach the value of US$ 836.3 Bn by the end of 2031.
Sleep Apnea Devices Market: The global sleep apnea devices market is expected to reach the value of US$ 14.7 Bn by the end of 2028.
Personal-use Facial and Skin Therapy Devices Market: The U.S. personal-use facial and skin therapy devices market is expected to reach the value of US$ 7.5 Bn by the end of 2031.
About Us
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com